173 related articles for article (PubMed ID: 10616005)
1. B cells lacking RP105, a novel B cell antigen, in systemic lupus erythematosus.
Koarada S; Tada Y; Ushiyama O; Morito F; Suzuki N; Ohta A; Miyake K; Kimoto M; Nagasawa K
Arthritis Rheum; 1999 Dec; 42(12):2593-600. PubMed ID: 10616005
[TBL] [Abstract][Full Text] [Related]
2. RP105-lacking B cells from lupus patients are responsible for the production of immunoglobulins and autoantibodies.
Kikuchi Y; Koarada S; Tada Y; Ushiyama O; Morito F; Suzuki N; Ohta A; Miyake K; Kimoto M; Horiuchi T; Nagasawa K
Arthritis Rheum; 2002 Dec; 46(12):3259-65. PubMed ID: 12483730
[TBL] [Abstract][Full Text] [Related]
3. Two cases of antinuclear antibody negative lupus showing increased proportion of B cells lacking RP105.
Koarada S; Ide M; Haruta Y; Tada Y; Ushiyama O; Morito F; Ohta A; Nagasawa K
J Rheumatol; 2005 Mar; 32(3):562-4. PubMed ID: 15742454
[TBL] [Abstract][Full Text] [Related]
4. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
[TBL] [Abstract][Full Text] [Related]
5. RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family.
Miyake K; Yamashita Y; Ogata M; Sudo T; Kimoto M
J Immunol; 1995 Apr; 154(7):3333-40. PubMed ID: 7897216
[TBL] [Abstract][Full Text] [Related]
6. Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells.
Sato S; Fujimoto M; Hasegawa M; Takehara K
Arthritis Rheum; 2004 Jun; 50(6):1918-27. PubMed ID: 15188368
[TBL] [Abstract][Full Text] [Related]
7. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
[TBL] [Abstract][Full Text] [Related]
8. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
[TBL] [Abstract][Full Text] [Related]
9. Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice.
Kobayashi T; Takahashi K; Nagai Y; Shibata T; Otani M; Izui S; Akira S; Gotoh Y; Kiyono H; Miyake K
Int Immunol; 2008 Jul; 20(7):881-91. PubMed ID: 18492657
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning of human RP105.
Fugier-Vivier I; de Bouteiller O; Guret C; Fossiez F; Banchereau J; Mattei MG; Aït-Yahia S; Garcia E; Lebecque S; Liu YJ
Eur J Immunol; 1997 Jul; 27(7):1824-7. PubMed ID: 9247598
[TBL] [Abstract][Full Text] [Related]
11. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
12. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.
Stohl W; Metyas S; Tan SM; Cheema GS; Oamar B; Xu D; Roschke V; Wu Y; Baker KP; Hilbert DM
Arthritis Rheum; 2003 Dec; 48(12):3475-86. PubMed ID: 14673998
[TBL] [Abstract][Full Text] [Related]
13. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
14. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
[TBL] [Abstract][Full Text] [Related]
15. CD40-activated B cells from patients with systemic lupus erythematosus can be modulated by therapeutic immunoglobulins in vitro.
Néron S; Boire G; Dussault N; Racine C; de Brum-Fernandes AJ; Côté S; Jacques A
Arch Immunol Ther Exp (Warsz); 2009; 57(6):447-58. PubMed ID: 19866343
[TBL] [Abstract][Full Text] [Related]
16. High-density expression of CD95 on B cells and underrepresentation of the B-1 cell subset in human lupus.
Huck S; Jamin C; Youinou P; Zouali M
J Autoimmun; 1998 Oct; 11(5):449-55. PubMed ID: 9802928
[TBL] [Abstract][Full Text] [Related]
17. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
19. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus.
Simpson N; Gatenby PA; Wilson A; Malik S; Fulcher DA; Tangye SG; Manku H; Vyse TJ; Roncador G; Huttley GA; Goodnow CC; Vinuesa CG; Cook MC
Arthritis Rheum; 2010 Jan; 62(1):234-44. PubMed ID: 20039395
[TBL] [Abstract][Full Text] [Related]
20. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
